2018-01-05 | Counterfeit Drugs and Patient Safety: A Real Threat

Imagine you or a loved one gets sick.  Typically, the first instinct most people have is to see if the illness goes away on its own—like a common cold.  If it doesn’t go away or gets worse, you may take the next logical step and get help by visiting a doctor.   After visiting the doctor, you receive a diagnosis and a prescription to help pave the way to recovery.  Next, the prescription is filled at a local pharmacy and you start taking the medication to get better.  This is a shared...

Read more »
2017-11-29 | Could Record Numbers Mean Record Counterfeiting?

Millions of people waited in line for deals, braved the crowds at the mall and scoured the web for just the right sale globally. This was the kickoff to holiday shopping season, and retailers know how important a strong start is to their bottom line. Especially when twenty percent of annual retail sales occur during the holiday season, you can’t take it lightly. With over $14 billion in sales, this holiday shopping weekend set records for online retailers. While shoppers are still recovering...

Read more »
2017-11-22 | Buyer Beware: The Truth About Counterfeiting This Holiday Season

 

Read more »
2017-11-10 | Europe's Readiness for the Falsified Medicines Directive is Lagging

 

GS1 Ireland and Enterprise System Partners (ESP) just published an interesting Serialization Industry Readiness Report 2017 .  The report is based on their survey of drug manufacturers, CMOs, virtual manufacturers and others who will fall under the European Union Falsified Medicines Directive (FMD) when it goes into effect on February 9, 2019.  The readiness survey was conducted between May and July 2017.
Read more »
2017-09-08 | Diversion in the Pharmaceuticals Market

The opioid crisis in the United States has been described as an epidemic requiring urgent action on the part of government, law enforcement, health advocates and other stakeholders. A substantial portion of overdose deaths result from opioids produced by reputable manufacturers for legitimate medical purposes that have been redirected to illegitimate use. This transfer of a legal substance to illegitimate or illicit use is known as diversion, and represents a major challenge in the...

Read more »
2017-08-04 | Our View: Yes, Serialization Can Improve Public Health

In a recent article, International Pharmaceutical Industry made the point that Serialization Improves Public Health.  We agree with that, up to a point.  The authors point out that drugs pass “…through a complex distribution network where [their] authenticity at every level cannot be checked due to the absence of data-sharing systems.”  Later in in the article they say, “…in the end serialization will help pharmaceutical companies to ensure patient safety.”  And, “…reliable serialization and...

Read more »
2017-04-14 | Don’t Put Your Brand and Your Customer’s Loyalty at Risk!

By Steve Tallant, Director, Product Management and Marketing

Until recently, counterfeit health and beauty products could not be verified as the actual product, or authenticated, quickly and cost-effectively. Unfortunately, counterfeiters have been able to obtain printing and imaging technologies that mimic the real thing. Furthermore, Internet-based distribution outlets have proliferated, and it is difficult to tell an e-retailer that sells legitimate products from one selling counterfeits.

Read more »